Michael Scolaro

Michael Scolaro

Dec 23, 2017

Group 6 Copy 1,192
-1
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

MyHealthEd

Each child deserves quality comprehensive sexual health education. No child is the same, so why...

Mathematical model to reduce maternal and infant mortality in Southeast Asia

Maternal and child mortality in Southeast Asian countries is still very high, especially in poor and rural...

Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia

Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...

Backer Badge Funded